CT News and Research

RSS

18FDG–PET–CT improves breast cancer staging

A prospective study has shown fluorodeoxyglucose positron emission tomography/computed tomography to be a powerful tool for the detection of nodal and distant metastatic disease in patients with breast cancer.

17 Dec 2012

‘Ambu-lysis’ edges closer for stroke patients

A pilot trial of giving suitable stroke patients intravenous thrombolysis before their arrival in hospital has produced promising results.

17 Dec 2012

Schizophrenia tends to be elevated in more urban communities: Study

Higher rates of schizophrenia in urban areas can be attributed to increased deprivation, increased population density and an increase in inequality within a neighbourhood, new research reveals.

15 Dec 2012

Meridian completes beta trials for two new illumigene molecular amplification tests

Meridian Bioscience, Inc. today announced that it has successfully completed beta trials for two new illumigene molecular amplification tests.

14 Dec 2012

Roundup: Mass. a template for controlling health care costs?; Fewer than expected use Minn. health care vouchers; Blue Shield in Calif.'s proposed rate hikes

This simple shift in how health care is paid for -- long seen as key to taming costs -- has been occurring in pockets of the country. But nowhere is it happening more systematically than in Massachusetts, the state that blazed a trail in 2006 by guaranteeing its residents health insurance. Now Massachusetts, a model for President Obama's 2010 national health care law, may offer another template for national leaders looking to control health spending.

13 Dec 2012

$Study finds increase in prevalence of nonrefractive visual impairment in the U.S.$

Study finds increase in prevalence of nonrefractive visual impairment in the U.S.

The prevalence of nonrefractive visual impairment (not due to need for glasses) in the U.S. has increased significantly in recent years, which may be partly related to a higher prevalence of diabetes, an associated risk factor, according to a study in the December 12 issue of JAMA.

12 Dec 2012

Roundup: NH hospital at center of hepatitis outbreak details fixes; Report finds racial gap in Colo. dental coverage; Health cuts part of Conn. budget plan

Though Exeter Hospital has fixed problems discovered after a hepatitis C outbreak last spring, federal officials say the hospital initially failed to conduct an adequate investigation. The Centers for Medicare and Medicaid Services said last week it no longer plans to terminate the hospital's Medicare funding now that multiple issues raised by inspectors have been addressed.

11 Dec 2012

Some stroke patients may benefit from cerebral angioplasty and stent placement

Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology.

11 Dec 2012

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

AMAG Pharmaceuticals, Inc. today announced that new data from two pivotal phase III clinical trials were presented at the American Society of Hematology's (ASH) annual meeting in Atlanta, Georgia.

11 Dec 2012

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Merrimack Pharmaceuticals, Inc. today announced Phase I clinical trial results for MM-302, the company's novel agent for the treatment of advanced HER2 positive (HER2+ or ErbB2+) breast cancer.

11 Dec 2012

Preliminary results from Boehringer Ingelheim’s volasertib Phase II study on AML

Boehringer Ingelheim Pharmaceuticals, Inc. today reported preliminary results from the randomized Phase II part of a Phase I/II study involving the company's investigational compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy.

11 Dec 2012

Erect radiographs reveal missed cervical spine instability

Erect radiographs are necessary to rule out unstable cervical spine injuries, UK researchers report.

10 Dec 2012

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Genentech, a member of the Roche Group, today announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy significantly extended the lives (overall survival) of people with previously untreated HER2-positive metastatic breast cancer (mBC), compared to Herceptin, chemotherapy and placebo.

10 Dec 2012

Christie rejects state-run health insurance exchange

The New Jersey governor said he didn't have enough information about the alternatives.

7 Dec 2012

Scheduled Medicare doctor pay cut could be just a few weeks away

Medscape and The Connecticut Mirror covered the looming 26.5 percent cut, mandated by the SGR law.

4 Dec 2012

Many physicians misinformed about initial diagnosis and treatment of epilepsy

A survey of healthcare providers concerning the initial diagnosis and treatment of epilepsy has found significant misinformation held among physicians who see children who have seizures. Many physicians surveyed are misinformed about what constitutes intractable epilepsy, when to refer their pediatric patients for surgical evaluation, and what types of seizures may be amenable to surgical intervention.

4 Dec 2012

Antidepressants in normal dosage may positively impact mood and seizure frequency

Epilepsy and depression are common co-morbidities. Concern for the potential of certain antidepressants to induce seizures has led to under-treating depression and anxiety disorders in epilepsy patients. Research presented today at the 66th American Epilepsy Society meeting suggests that antidepressants in normal dosage may have a positive impact on both mood and seizure frequency.

4 Dec 2012

Studies explore F-18-FLT PET utility in providing prognostic information for patients with gliomas

In the management of gliomas-or tumors that originate in the brain-precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival.

4 Dec 2012

Link between stress and brain activation in patients with seizure

A study reported here at the 66th American Epilepsy Society Annual Meeting has identified a significant difference in the brain response to stress in patients who believe stress is an important factor in their seizure control compared to patients who do not hold this belief.

4 Dec 2012

Certain patients with prostate cancer may benefit from Provenge clinical trial

Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.

4 Dec 2012

CT News and Research

18FDG–PET–CT improves breast cancer staging

‘Ambu-lysis’ edges closer for stroke patients

Schizophrenia tends to be elevated in more urban communities: Study

Meridian completes beta trials for two new illumigene molecular amplification tests

Roundup: Mass. a template for controlling health care costs?; Fewer than expected use Minn. health care vouchers; Blue Shield in Calif.'s proposed rate hikes

Study finds increase in prevalence of nonrefractive visual impairment in the U.S.

Roundup: NH hospital at center of hepatitis outbreak details fixes; Report finds racial gap in Colo. dental coverage; Health cuts part of Conn. budget plan

Some stroke patients may benefit from cerebral angioplasty and stent placement

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Preliminary results from Boehringer Ingelheim’s volasertib Phase II study on AML

Erect radiographs reveal missed cervical spine instability

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Christie rejects state-run health insurance exchange

Scheduled Medicare doctor pay cut could be just a few weeks away

Many physicians misinformed about initial diagnosis and treatment of epilepsy

Antidepressants in normal dosage may positively impact mood and seizure frequency

Studies explore F-18-FLT PET utility in providing prognostic information for patients with gliomas

Link between stress and brain activation in patients with seizure

Certain patients with prostate cancer may benefit from Provenge clinical trial

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News